Skip to main content
Equibles

Peter Green

Analyst

LifeSci Capital

Equibles does not estimate personal net worth.

About Peter Green

Peter Green is recorded as Analyst at LifeSci Capital. Peter Green has spoken on 1 investor event across 1 company, most recently for Kura Oncology, Inc. on October 13, 2026. The companies whose calls Peter Green spoke on are classified in the Healthcare sector.

Peter Green on recent calls

“Question for the team, how might this phase one trial or future trials be designed to show 7246's potential unique contribution to glycemic control as compared to other background therapies that patients might come in the trial on?”
Analyst — LifeSci Capital, Kura Oncology EASD Virtual Investor Event ·

Affiliation history

  • LifeSci Capital

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity